Last reviewed · How we verify

NCT05256615

Exercise Timing and Gestational Diabetes

Completed NA Last updated 24 July 2024
What this trial tests

NA trial testing 30-minute walking intervention in Pregnancy Related in 41 participants. Completed in 7 June 2024.

Timeline
1 January 2020
Primary endpoint
7 June 2024
7 June 2024

Quick facts

Lead sponsorUniversity of Alberta
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment41
Start date1 January 2020
Primary completion7 June 2024
Estimated completion7 June 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Alberta

Who can join

Adults 18 to 45, female only, with Pregnancy Related or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to understand if the timing of exercise around food intake can help improve blood sugar management in pregnant individuals with diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Optimizing Blood Glucose Control through the Timing of Exercise in Pregnant Individuals Diagnosed with Gestational Diabetes Mellitus.
    Brislane Á, Reid LA, Bains G, Greenwall K, et al · · 2023 · cited 1× · PMID 37107782 · DOI 10.3390/ijerph20085500

Verify or expand the search:

Other recruiting trials for Pregnancy Related

Currently open trials in the same condition.

Other University of Alberta trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05256615.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing